The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

p66shc Adaptor Protein Suppresses the Activation of Endothelial Nitric Oxide Synthase in Mouse Embryonic Fibroblasts

  • Lee, Sang-Ki (Department of Physiology, College of Medicine, Chungnam National University) ;
  • Kim, Young-Shin (Department of Physiology, College of Medicine, Chungnam National University) ;
  • Kim, Cuk-Seong (Department of Physiology, College of Medicine, Chungnam National University) ;
  • Son, Sook-Jin (Department of Physiology, College of Medicine, Chungnam National University) ;
  • Yoo, Dae-Goon (Department of Physiology, College of Medicine, Chungnam National University) ;
  • Lee, Kwon-Ho (Department of Physiology, College of Medicine, Chungnam National University) ;
  • Lee, Sang-Do (Department of Physiology, College of Medicine, Chungnam National University) ;
  • Park, Jin-Bong (Department of Physiology, College of Medicine, Chungnam National University) ;
  • Jeon, Byeong-Hwa (Department of Physiology, College of Medicine, Chungnam National University)
  • Published : 2006.06.21
Download PDF
⟨ Previous Next ⟩

Abstract

Among the Shc proteins, p66shc is known to be related to oxidative stress responses and regulation of the production of reactive oxygen species (ROS). The present study was undertaken to investigate the role of p66shc on endothelial nitric oxide synthase (eNOS) activity in the mouse embryonic fibroblasts (MEFs). When wild type (WT) or p66shc (-/-) MEFs were transfected with full length of eNOS cDNA, the expression and activity of eNOS protein were higher in the p66shc (-/-) MEFs. These phenomena were reversed by reconstitution of p66shc cDNA transfection in the p66shc (-/-) MEFs. The basal superoxide production in the p66shc (-/-) MEFs was not significantly different from that of WT of MEFs. However, superoxide production induced by NADPH in the p66shc (-/-) MEF was lesser than that in WT MEFs. When compared with WT MEFs, cell lysate of p66shc (-/-) MEFs showed significantly increased H-ras activity without change of endogenous H-ras expression. Our findings suggest the pivotal role of p66shc adaptor protein played in inhibition of endothelial nitric oxide production via modulation of the expression and/or activity of eNOS protein.

Keywords

References

  1. Bonfini L, Migliaccio E, Pelicci G, Lanfrancone L, Pelicci PG. Not all Shc's roads lead to Ras. Trends Biochem Sci 21: 257-261, 1996 https://doi.org/10.1016/S0968-0004(96)10033-5
  2. Fleming I, Busse R. Signal transduction of eNOS activation. Cardiovasc Res 43: 532-541, 1999 https://doi.org/10.1016/S0008-6363(99)00094-2
  3. Foschi M, Franchi F, Han J, La Villa G, Sorokin A. Endothelin-1 induces serine phosphorylation of the adaptor protein p66Shc and its association with 14-3-3 protein in glomerular mesangial cells. J Biol Chem 276: 26640-26647, 2001 https://doi.org/10.1074/jbc.M102008200
  4. Francia P, delli Gatti C, Bachschmid M, Martin-Padura I, Savoia C, Migliaccio E, Pelicci PG, Schiavoni M, Luscher TF, Volpe M, Cosentino F. Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation 110: 2889-2895, 2004 https://doi.org/10.1161/01.CIR.0000147731.24444.4D
  5. Jeon BH, Gupta G, Park YC, Qi B, Haile A, Khanday FA, Liu YX, Kim JM, Ozaki M, White AR, Berkowitz DE, Irani K. Apurinic/ apyrimidinic endonuclease 1 regulates endothelial NO production and vascular tone. Circ Res 95: 902-910, 2004 https://doi.org/10.1161/01.RES.0000146947.84294.4c
  6. Kawashima S. Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase/NO system in atherosclerosis. J Pharmacol Sci 96: 411-419, 2004 https://doi.org/10.1254/jphs.FMJ04006X6
  7. Kim CS, Son SJ, Kim EK, Kim SN, Yoo DG, Kim HS, Ryoo SW, Lee SD, Irani K, Jeon BH. Apurinic/apyrimidinic endonuclease1/ redox factor-1 inhibits monocyte adhesion in endothelial cells. Cardiovasc Res 69: 520-526, 2006 https://doi.org/10.1016/j.cardiores.2005.10.014
  8. Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, Bar-Sagi D, Margolis B, Schlessinger J. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363: 85-88, 1993 https://doi.org/10.1038/363085a0
  9. Luzi L, Confalonieri S, Di Fiore PP, Pelicci PG. Evolution of Shc functions from nematode to human. Curr Opin Genet Dev 10: 668-674, 2000 https://doi.org/10.1016/S0959-437X(00)00146-5
  10. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25: 29-38, 2005
  11. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L, Pelicci PG. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402: 309-313, 1999 https://doi.org/10.1038/46311
  12. Migliaccio E, Mele S, Salcini AE, Pelicci G, Lai KM, Superti-Furga G, Pawson T, Di Fiore PP, Lanfrancone L, Pelicci PG. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. Embo J 16: 706-716, 1997 https://doi.org/10.1093/emboj/16.4.706
  13. Molavi B, Mehta JL. Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr Opin Cardiol 19: 488-493, 2004 https://doi.org/10.1097/01.hco.0000133657.77024.bd
  14. Napoli C, Martin-Padura I, de Nigris F, Giorgio M, Mansueto G, Somma P, Condorelli M, Sica G, De Rosa G, Pelicci P. Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci USA 100: 2112-2116, 2003
  15. Nemoto S, Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295: 2450- 2452, 2002 https://doi.org/10.1126/science.1069004
  16. Okada S, Kao AW, Ceresa BP, Blaikie P, Margolis B, Pessin JE. The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway. J Biol Chem 272: 28042-28049, 1997 https://doi.org/10.1074/jbc.272.44.28042
  17. Pagnin E, Fadini G, de Toni R, Tiengo A, Calo L, Avogaro A. Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress. J Clin Endocrinol Metab 90: 1130-1136, 2005 https://doi.org/10.1210/jc.2004-1283
  18. Robinson LJ, Busconi L, Michel T. Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J Biol Chem 270: 995- 998, 1995 https://doi.org/10.1074/jbc.270.3.995
  19. Robinson LJ, Michel T. Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting. Proc Natl Acad Sci USA 92: 11776-11780, 1995
  20. Shaul PW. Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64: 749-774, 2002 https://doi.org/10.1146/annurev.physiol.64.081501.155952
  21. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1381-1478, 2004 https://doi.org/10.1152/physrev.00047.2003
  22. Ugi S, Sharma PM, Ricketts W, Imamura T, Olefsky JM. Phosphatidylinositol 3-kinase is required for insulin-stimulated tyrosine phosphorylation of Shc in 3T3-L1 adipocytes. J Biol Chem 277: 18592-18597, 2002 https://doi.org/10.1074/jbc.M201019200
  23. Yamamori T, White AR, Mattagajasingh I, Khanday FA, Haile A, Qi B, Jeon BH, Bugayenko A, Kasuno K, Berkowitz DE, Irani K. P66shc regulates endothelial NO production and endothelium- dependent vasorelaxation: implications for age-associated vascular dysfunction. J Mol Cell Cardiol 39: 992-995, 2005 https://doi.org/10.1016/j.yjmcc.2005.09.003